Elixir Pharmaceuticals withdraws IPO
5/9/2008
Elixir Pharmaceuticals, which develops treatments for metabolic diseases such as diabetes and obesity, withdrew its IPO in a filing with the SEC on Friday. The company had planned to offer 5 million shares at a price range of $14 to $16, but postponed its offering in January 2008. Credit Suisse was set to be the lead manager on the deal.
View IPO Profile:
ELXR
|
Biopharmaceutical company Aldagen files for IPO
5/9/2008
Aldagen, which develops regenerative call therapies using proprietary adult stem cell technologies, filed with the SEC for an IPO on Friday. The Durham, NC-based company has applied to list its common stock on the NASDAQ under the ticker ALDH. Cowen & Company and Wachovia Securities are the lead underwriters on the deal. No terms were disclosed in the initial filing.
View IPO Profile:
ALDH
|
Western Gas Partners L.P. prices below range
5/8/2008
Western Gas Partners L.P., which gathers, compresses, treats and transports natural gas for its parent Anadarko and other customers, priced its 18.8 million unit offering at $16.50 on Thursday, 8% below the midpoint of the proposed range. The units are expected to begin trading Friday on the NYSE under the ticker WES. UBS, Citi, Credit Suisse and Morgan Stanley were the lead underwriters on the deal.
View IPO Profile:
WES
|
Noranda Aluminum Holding files for IPO
5/8/2008
Noranda Aluminum Holding, a vertically integrated producer of value-added primary aluminum products and rolled coils, filed with the SEC for an IPO on Thursday. The Apollo Management-backed company booked $1.4 billion in sales in 2007 and plans to list on the NYSE under the ticker NOR. No underwriters or terms were disclosed in the initial filing.
View IPO Profile:
|
Wind energy company Noble Environmental Power files for IPO
5/8/2008
Noble Environmental Power, a wind energy company operating 282 megawatts of electrical generating capacity, filed with the SEC for an IPO on Thursday. The company is backed by a private equity division of JPMorgan Chase and plans to list on the NASDAQ under the ticker NEPI. Lehman Brothers, JPMorgan and Credit Suisse are the lead underwriters on the deal. No terms were disclosed in the initial filing.
View IPO Profile:
NEPI
|
